186 related articles for article (PubMed ID: 34558100)
1. Role of mass spectrometry in the study of interactions between amylin and metal ions.
Moracci L; Crotti S; Traldi P; Agostini M; Cosma C; Lapolla A
Mass Spectrom Rev; 2023 May; 42(3):984-1007. PubMed ID: 34558100
[TBL] [Abstract][Full Text] [Related]
2. Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.
Li H; Ha E; Donaldson RP; Jeremic AM; Vertes A
Anal Chem; 2015 Oct; 87(19):9829-9837. PubMed ID: 26352401
[TBL] [Abstract][Full Text] [Related]
3. Stepwise oligomerization of murine amylin and assembly of amyloid fibrils.
Palmieri LC; Melo-Ferreira B; Braga CA; Fontes GN; Mattos LJ; Lima LM
Biophys Chem; 2013; 180-181():135-44. PubMed ID: 23974296
[TBL] [Abstract][Full Text] [Related]
4. Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors.
Young LM; Cao P; Raleigh DP; Ashcroft AE; Radford SE
J Am Chem Soc; 2014 Jan; 136(2):660-70. PubMed ID: 24372466
[TBL] [Abstract][Full Text] [Related]
5. The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme.
Bellia F; Grasso G
J Mass Spectrom; 2014 Apr; 49(4):274-9. PubMed ID: 24719342
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the copper binding site on the human islet amyloid polypeptide hormone.
Kim MJ; Kim HT
Eur J Mass Spectrom (Chichester); 2012; 18(1):51-8. PubMed ID: 22792614
[TBL] [Abstract][Full Text] [Related]
7. Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.
Susa AC; Wu C; Bernstein SL; Dupuis NF; Wang H; Raleigh DP; Shea JE; Bowers MT
J Am Chem Soc; 2014 Sep; 136(37):12912-9. PubMed ID: 25144879
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the assembly and amyloid aggregation of murine amylin by zinc.
Erthal LC; Marques AF; Almeida FC; Melo GL; Carvalho CM; Palmieri LC; Cabral KM; Fontes GN; Lima LM
Biophys Chem; 2016 Nov; 218():58-70. PubMed ID: 27693831
[TBL] [Abstract][Full Text] [Related]
9. Studies on the cross-interaction between hIAPP and Aβ
Pang B; Zhuang X; Bian X; Liu S; Liu Z; Song F
J Mass Spectrom; 2020 Oct; 55(10):e4643. PubMed ID: 32893436
[TBL] [Abstract][Full Text] [Related]
10. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
Aitken JF; Loomes KM; Riba-Garcia I; Unwin RD; Prijic G; Phillips AS; Phillips ARJ; Wu D; Poppitt SD; Ding K; Barran PE; Dowsey AW; Cooper GJS
Biochem Biophys Res Commun; 2017 Jan; 482(4):625-631. PubMed ID: 27865831
[TBL] [Abstract][Full Text] [Related]
11. New Insight in Copper-Ion Binding to Human Islet Amyloid: The Contribution of Metal-Complex Speciation To Reveal the Polypeptide Toxicity.
Magrì A; La Mendola D; Nicoletti VG; Pappalardo G; Rizzarelli E
Chemistry; 2016 Sep; 22(37):13287-300. PubMed ID: 27493030
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage.
Khemtemourian L; Antoniciello F; Sahoo BR; Decossas M; Lecomte S; Ramamoorthy A
Chem Phys Lipids; 2021 Jul; 237():105083. PubMed ID: 33887213
[TBL] [Abstract][Full Text] [Related]
13. An electrospray ionization study on complexes of amylin with Cu(II) and Cu(I).
Moracci L; Crotti S; Traldi P; Cosma C; Lapolla A; Pucciarelli S; Agostini M
J Mass Spectrom; 2021 Jul; 56(7):e4773. PubMed ID: 34120371
[TBL] [Abstract][Full Text] [Related]
14. Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP.
Zhang M; Hu R; Liang G; Chang Y; Sun Y; Peng Z; Zheng J
J Phys Chem B; 2014 Jun; 118(25):7026-36. PubMed ID: 24892388
[TBL] [Abstract][Full Text] [Related]
15. Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry.
Young LM; Mahood RA; Saunders JC; Tu LH; Raleigh DP; Radford SE; Ashcroft AE
Analyst; 2015 Oct; 140(20):6990-9. PubMed ID: 26193839
[TBL] [Abstract][Full Text] [Related]
16. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
17. Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources.
Berardet C; Kaffy J; Halgand F; Van der Rest G; Ongeri S; Taverna M
Anal Bioanal Chem; 2020 May; 412(13):3103-3111. PubMed ID: 32211924
[TBL] [Abstract][Full Text] [Related]
18. Interaction of amylin species with transition metals and membranes.
Alghrably M; Czaban I; Jaremko Ł; Jaremko M
J Inorg Biochem; 2019 Feb; 191():69-76. PubMed ID: 30468944
[TBL] [Abstract][Full Text] [Related]
19. Zinc-Induced Conformational Transitions in Human Islet Amyloid Polypeptide and Their Role in the Inhibition of Amyloidosis.
Ilitchev AI; Giammona MJ; Schwarze JN; Buratto SK; Bowers MT
J Phys Chem B; 2018 Nov; 122(43):9852-9859. PubMed ID: 30299960
[TBL] [Abstract][Full Text] [Related]
20. Understanding the structural dynamics of human islet amyloid polypeptide: Advancements in and applications of ion-mobility mass spectrometry.
Dai Z; Ben-Younis A; Vlachaki A; Raleigh D; Thalassinos K
Biophys Chem; 2024 Jun; 312():107285. PubMed ID: 38941872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
